Loading
Training program / Early Stage Breast Cancer · Interventional Study
ClinicalTrials.gov · September 10, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a registry record for an active, multisite pilot trial examining whether a structured 6-month combined resistance and aerobic exercise program improves quality-of-life outcomes in early-stage breast cancer patients receiving adjuvant aromatase inhibitors with or without CDK4/6 inhibitors. No results are yet available; the study is recruiting and will provide preliminary feasibility and effect size data to inform future larger trials.
Interventional, Randomized, Parallel, Open label, Supportive Care purpose. Early-stage Breast Cancer; Female; age from 18 Years. Intervention: Experimental group. Compared with: Control group — No Intervention. n = 74. 5 sites: Spain.
This is a registry record for an active, multisite pilot trial examining whether a structured 6-month combined resistance and aerobic exercise program improves quality-of-life outcomes in early-stage breast cancer patients receiving adjuvant aromatase inhibitors with or without CDK4/6 inhibitors. No results are yet available; the study is recruiting and will provide preliminary feasibility and effect size data to inform future larger trials.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This pilot will provide preliminary data on the feasibility and effect of structured exercise on quality of life during endocrine therapy for early breast cancer. Results may inform the design of a larger definitive trial but should not yet guide individual clinical practice.
This is a recruiting pilot trial with no results posted; it is early-phase and designed to explore feasibility and effect of exercise on quality of life in early breast cancer patients on adjuvant endocrine therapy.
As stated by the source record.
Quoted from the source exactly as published.
This pilot will provide preliminary data on the feasibility and effect of structured exercise on quality of life during endocrine therapy for early breast cancer. Results may inform the design of a larger definitive trial but should not yet guide individual clinical practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07215364). This is a study registration, not published results. Lead sponsor: Spanish Breast Cancer Research Group. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 74 participants (ESTIMATED). Conditions: Early-stage Breast Cancer. Interventions: BEHAVIORAL: Training program. Primary outcome measures: Effect of a training program in quality of life questionnaire (QoL)-related to endocrine therapy , Through study treatment, and average of 12 months. Brief summary: This is a national clinical trial (Spain), conducted in approximately 5 sites, where patients who agree to participate will be included in one of two exercise program groups: the experimental group (a combined resistance and aerobic exercise program) and the control group. The study will begin with a pilot phase involving approximately 74 patients. Approximately 37 patients in the experimental group will follow a 6-month training program consisting of exercise sessions three alternate days per week (combining resistance and aerobic exercise). Approximately 37 patients in the control group will receive standard medical care. These patients will be provided with international exercise guidelines for cancer patients. Patients will continue with their assigned physical activity intervention until the maximum number of months for the intervention, unacceptable toxicity, discontinuation of hormone therapy, or withdrawal of consent-whichever occurs first.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.